Difference between revisions of "Paclitaxel, nanoparticle albumin-bound (Abraxane)"
Jump to navigation
Jump to search
(Created page with "==General information== Class: Taxane, promotes assembly of microtubules, stablizes microtubules, preventin depolymerization, inhibiting interphase/mitosis processes<ref name="in...") |
|||
| Line 1: | Line 1: | ||
==General information== | ==General information== | ||
| − | Class: Taxane, promotes assembly of microtubules, stablizes microtubules, | + | Class: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes<ref name="insert">[http://www.abraxane.com/docs/Abraxane_PrescribingInformation.pdf Paclitaxel, albumin-bound (Abraxane) package insert]</ref><ref>[http://hemonc.org/docs/chemotherapypackageinsert/aldesleukin.pdf Paclitaxel, albumin-bound (Abraxane) package insert (locally hosted backup)]</ref> |
<br>Extravasation: [[irritant]] | <br>Extravasation: [[irritant]] | ||
| − | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>. | + | For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>. |
==Patient drug information== | ==Patient drug information== | ||
Revision as of 08:11, 27 November 2011
General information
Class: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes[1][2]
Extravasation: irritant
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the package insert[1].
Patient drug information
Regimens
Standard format will be:
<acronym (if any)> (generic drug1, generic drug2, generic drug3, etc.) (disease)